Considering gemcitabine-based combination chemotherapy as a potential treatment for advanced oesophageal cancer: A meta-analysis of randomised trials.
Jian YangXiao LiangYuanfang ZhaiXiaoling HuZhiwu JiaXiaolong ChengPublished in: International journal of clinical practice (2020)
The improvements of gemcitabine-based combination chemotherapy on RR, CDR and reduction of gastrointestinal tract, hepatic and renal for EC patients suggests that the combined chemotherapy based on gemcitabine could be a potential treatment options for advanced EC.
Keyphrases
- locally advanced
- rectal cancer
- end stage renal disease
- squamous cell carcinoma
- radiation therapy
- clinical trial
- ejection fraction
- chronic kidney disease
- newly diagnosed
- human health
- peritoneal dialysis
- papillary thyroid
- prognostic factors
- open label
- risk assessment
- patient reported outcomes
- study protocol
- double blind
- climate change
- placebo controlled